Pharma channel feed

Aque­s­tive nabs FDA OK for oral film ver­sion of gener­ic ALS drug

6 years ago
FDA+

FDA re­leas­es 81 prod­uct-spe­cif­ic guid­ances

6 years ago
FDA+

Sanofi's strat­e­gy head to re­tire by month end, as com­pa­ny gears up for De­cem­ber strate­gic up­date

6 years ago
People

Ahead of strate­gic up­date, new Sanofi CEO mulls op­tions for con­sumer health­care arm — re­ports

6 years ago
Deals

Eli Lil­ly touts $400M man­u­fac­tur­ing ex­pan­sion, 100 new jobs to much fan­fare in In­di­anapo­lis — even though it's been chop­ping staff

6 years ago

As­traZeneca los­es an­oth­er ex­ec­u­tive to biotech, as Badrul Chowd­hury moves to Savara

6 years ago
People

Eliz­a­beth War­ren pro­pos­es us­ing com­pul­so­ry li­cens­ing, an­titrust ac­tions to break bio­phar­ma’s con­trol of drug pric­ing — and here are the block­busters she’s tar­get­ing first

6 years ago
Bioregnum
Opinion

Af­ter a late-stage miss, No­var­tis touts an­oth­er En­tresto analy­sis to con­vince the FDA to ex­pand the block­buster's la­bel

6 years ago
R&D

FTC clears Bris­tol-My­ers’ $74B deal to buy Cel­gene — but Dems sig­nal a po­ten­tial hard shift against Big Phar­ma M&A

6 years ago

FDA pan­el large­ly op­pos­es ex­pand­ing use of Lil­ly, Boehringer's SGLT2 in­hibitor to type 1 di­a­bet­ics

6 years ago
R&D

Mer­ck shut­ters French re­search site in a re­or­ga­ni­za­tion aimed at elim­i­nat­ing more than 200 jobs

6 years ago

Vot­ers say Con­gress needs to curb drug prices. So why do the odds look grim for ma­jor leg­is­la­tion this year?

6 years ago

FDA to re­voke or­phan des­ig­na­tion for opi­oid ad­dic­tion drug Sublo­cade

6 years ago
FDA+

Fol­low­ing a win for Baven­cio, Pfiz­er and Mer­ck KGaA con­tin­ue PD-L1 los­ing streak

6 years ago
R&D

Eye­ing sec­ond Japan­ese ap­proval, Dai­ichi and Ex­elix­is an­nounce pos­i­tive piv­otal for kid­ney drug

6 years ago
R&D

Tri­fec­ta of in­com­ing mi­graine meds must be cheap­er than trip­tans to be cost-ef­fec­tive — ICER

6 years ago

Durbin push­es for Sen­ate vote on bill to in­clude drug prices in ads

6 years ago

Ear­ly da­ta on Takeda's dengue vac­cine is promis­ing, but wait for the full dataset

6 years ago
R&D

HHS is tak­ing Gilead to court, seek­ing dam­ages for in­fring­ing gov­ern­ment HIV patents

6 years ago
FDA+

On the heels of a $6.9B As­traZeneca pact, IP dis­pute be­tween Dai­ichi Sankyo and Seat­tle Ge­net­ics rips open in law­suit

6 years ago
R&D

Is FDA do­ing enough to bring biosim­i­lars to mar­ket? Ex­perts dis­cuss

6 years ago
FDA+

As­traZeneca wins ku­dos for pipeline turn­around in a new rank­ing of the top 10 R&D play­ers in the bio­phar­ma world

6 years ago
R&D

Worth­less? Short at­tack on Fi­bro­Gen claims their ane­mia drug roxa has a lethal Achilles’ heel — and it’s go­ing down

6 years ago
R&D

Right on dead­line, Trump taps Stephen Hahn as new FDA com­mish. Now what?

6 years ago
People
First page Previous page 259260261262263264265 Next page Last page
A service from the Financial Times